Watch OMDA. Know when insiders buy.
One email the day a filing lands. Free.
Work order
65
PASS · insiders 30, shorts 100
Insiders, 90 days
−$537K
net selling · 0 buys, 5 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.4BP/E 99.0DIV YIELD —FCF YIELD 1.63%REV TTM $309.8M +47.6%NET INCOME $4.3MNET CASH $221.7M52W 10.94 – 26.78SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $87.8M | +43.1% | 72.6% | $3.5M | $5.3M | — | 0.08 | $4M | $146K | $3.9M | Aug 7 |
| Q1 2026 · Mar 31 | $78M | +42.0% | 62.4% | −$4.8M | −$3M | — | -0.05 | −$11.8M | $78K | −$11.9M | Aug 7 |
| Q4 2025 · Dec 31derived | $75.8M | +58.1% | 70.8% | $3.3M | $5.2M | — | 0.26 | $21.4M | $199K | $21.2M | Mar 6 |
| Q3 2025 · Sep 30 | $68M | +49.5% | 66.3% | −$2.5M | −$3.2M | — | -0.06 | $10.1M | $537K | $9.6M | Nov 7 |
| Q2 2025 · Jun 30 | $61.4M | +48.9% | 65.7% | −$4.3M | −$5.3M | — | -0.24 | $2.9M | $271K | $2.6M | Aug 7 |
| Q1 2025 · Mar 31 | $55M | — | 58.0% | −$8.4M | −$9.4M | — | -1.15 | −$16.1M | $315K | −$16.4M | Aug 7 |
| Q4 2024 · Dec 31derived | $48M | — | 67.0% | −$7.1M | −$8.3M | — | -1.02 | −$6.5M | $184K | −$6.7M | Mar 6 |
| Q3 2024 · Sep 30 | $45.5M | — | 62.8% | −$8.5M | −$9.2M | — | -1.18 | $1.1M | $76K | $980K | Nov 7 |
| Q2 2024 · Jun 30 | $41.2M | — | 60.3% | −$10M | −$10.7M | — | -1.40 | — | — | — | Nov 7 |
| Q1 2024 · Mar 31 | — | — | — | — | −$19M | — | — | — | — | — | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $260.2M | 65.7% | −$12M | −$12.8M | -4.9% | -0.35 | $18.3M | $1.3M | $16.9M | — | — |
| FY2024 · to Dec 31 | $169.8M | 60.6% | −$43.7M | −$47.1M | -27.8% | -6.11 | −$34.2M | $596K | −$34.8M | — | — |
| FY2023 · to Dec 31 | $122.8M | 57.0% | −$66M | −$67.5M | -55.0% | -9.52 | −$49.7M | $416K | −$50.2M | — | — |
Every number comes from Omada Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.